Page last updated: 2024-10-27

fluoxetine and Disease Resistance

fluoxetine has been researched along with Disease Resistance in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Disease Resistance: The capacity of an organism to defend itself against pathological processes or the agents of those processes. This most often involves innate immunity whereby the organism responds to pathogens in a generic way. The term disease resistance is used most frequently when referring to plants.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kassa, FA1
Van Den Ham, K1
Rainone, A1
Fournier, S1
Boilard, E1
Olivier, M1

Other Studies

1 other study available for fluoxetine and Disease Resistance

ArticleYear
Absence of apolipoprotein E protects mice from cerebral malaria.
    Scientific reports, 2016, 09-20, Volume: 6

    Topics: Animals; Apolipoproteins E; Blood-Brain Barrier; Brain; Cytokines; Disease Models, Animal; Disease R

2016